Vicadrostat, also known as BI 690517 (1) is a novel, potent, and selective aldosterone synthase CYP11B2 inhibitor being developed in combination with empagliflozin to slow the progression of kidney damage and reduce cardiovascular events in people with chronic... ...

请注册登录后继续浏览